Zachary Zuschlag to Adrenergic Uptake Inhibitors
This is a "connection" page, showing publications Zachary Zuschlag has written about Adrenergic Uptake Inhibitors.
Connection Strength
0.050
-
Atomoxetine in comorbid ADHD/PTSD: A randomized, placebo controlled, pilot, and feasibility study. Depress Anxiety. 2022 04; 39(4):286-295.
Score: 0.050
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.